| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 07/26/2001 | CA2398695A1 Chondromodulin-i related peptide |
| 07/26/2001 | CA2398061A1 Substituted glutarimides and their use as inhibitors of il-12 production |
| 07/26/2001 | CA2397946A1 Lipid metabolism enzymes |
| 07/26/2001 | CA2397774A1 Jak/stat pathway inhibitors and the uses thereof |
| 07/26/2001 | CA2397633A1 Corticotropin releasing factor antagonists |
| 07/26/2001 | CA2397627A1 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 07/26/2001 | CA2397565A1 Food product and process |
| 07/26/2001 | CA2397508A1 Outer membrane vesicle (omv) vaccine comprising n. meningitidis serogroup b outer membrane proteins |
| 07/26/2001 | CA2397205A1 Antisense modulation of macrophage migration inhibitory factor expression |
| 07/26/2001 | CA2396979A1 Immune modulation with death receptor-induced apoptosis |
| 07/26/2001 | CA2396908A1 Benzimidazole derivative |
| 07/26/2001 | CA2396870A1 Particulate blends and compacted products formed therefrom, and the preparation thereof |
| 07/26/2001 | CA2396212A1 Recombinant antibodies to human interleukin-1 beta |
| 07/26/2001 | CA2395054A1 Human polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2394753A1 Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies |
| 07/26/2001 | CA2365118A1 Inhibitor against human chymase activity |
| 07/25/2001 | EP1118858A2 Assay method |
| 07/25/2001 | EP1118663A1 Nucleic acids encoding chemotaxis inhibitory polypeptides |
| 07/25/2001 | EP1118324A1 Analgesic agent comprising a cyclobutanedicarboxylic acid derivative |
| 07/25/2001 | EP1117817A2 Therapeutically active proteins in plants |
| 07/25/2001 | EP1117796A2 Calcium channel alpha-2/delta gene |
| 07/25/2001 | EP1117785A1 Human kinesin-like motor protein |
| 07/25/2001 | EP1117782A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 07/25/2001 | EP1117781A2 Human membrane channel proteins |
| 07/25/2001 | EP1117776A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 07/25/2001 | EP1117695A1 Biocompatible polymers, preparation method and compositions containing same |
| 07/25/2001 | EP1117685A1 Treatment of inflammatory disease |
| 07/25/2001 | EP1117684A1 Chemical structure with affinity for a phospholipid, and marker compound, diagnosis kit, and medicine comprising said structure |
| 07/25/2001 | EP1117682A1 Novel peptides |
| 07/25/2001 | EP1117681A1 Novel peptides |
| 07/25/2001 | EP1117675A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 07/25/2001 | EP1117662A1 Benzimidazolinyl piperidines as cgrp ligands |
| 07/25/2001 | EP1117658A1 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders |
| 07/25/2001 | EP1117657A1 Phenylalanine derivatives as alpha 4 integrin inhibitors |
| 07/25/2001 | EP1117653A1 Chemical compounds |
| 07/25/2001 | EP1117648A1 Tetrahydroquinoline derivatives having selective activity for retinoid x receptors |
| 07/25/2001 | EP1117646A1 Phenylalkanoic acid derivatives as inhibitors of alpha4 integrins |
| 07/25/2001 | EP1117633A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 07/25/2001 | EP1117443A1 Peptide-based carrier devices for stellate cells |
| 07/25/2001 | EP1117441A2 Biodegradable terephthalate polyester-poly(phosphonate) and polyester-poly(phosphite) compositions, articles, and methods of using them |
| 07/25/2001 | EP1117438A1 Tie2 antagonist antibodies |
| 07/25/2001 | EP1117432A1 Carbohydrate vaccines for viral diseases |
| 07/25/2001 | EP1117414A1 Reduction of oxidative stress factors |
| 07/25/2001 | EP1117403A1 Mglur5 antagonists for the treatment of pain and anxiety |
| 07/25/2001 | EP1117402A2 Antibiotic compositions for treatment of the eye, ear and nose |
| 07/25/2001 | EP1117398A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 07/25/2001 | EP1117397A1 Geometrically restricted 2-indolinone derivatives as modulators of protein kinase activity |
| 07/25/2001 | EP1117390A1 Mucosal originated drug delivery systems and animal applications |
| 07/25/2001 | EP1117389A1 Method of making pressure sensitive adhesive matrix patches containing hydrophilic salts of drugs |
| 07/25/2001 | EP1117384A1 Controlled release nanoparticulate compositions |
| 07/25/2001 | EP1117356A1 Methods and apparatus for improved administration of fentanyl and sufentanil |
| 07/25/2001 | EP1117296A1 Combination of bisphosphonate and tetracycline |
| 07/25/2001 | EP0854860B1 A new family of compounds having anti-inflammatory and anti-viral activity and compositions of these, alone and in combination with reverse transcriptase inhibitors, for inhibiting, preventing or eliminating viral replication and methods of using same |
| 07/25/2001 | EP0794955B1 Hindered n-oxide esters of rapamycin and their use as medicaments |
| 07/25/2001 | EP0788362B1 Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism |
| 07/25/2001 | EP0772610B9 Dihydrobenzofuranes |
| 07/25/2001 | CN1305527A Vasculogenesis correlation molecule |
| 07/25/2001 | CN1305496A Cyclic somatostatin analogs |
| 07/25/2001 | CN1305493A Novel cyclosporins |
| 07/25/2001 | CN1305491A Crystalline forms of 1S-[1a(pha(2S, 3R), 9alpha]-6,10-dioxo-N-(2-ethoxy-5-oxo-tetrahydro-3-furanyl)-9-[[(1-isoquinolyl)carbonyl]-amino] actahydro-6H-piridazino [1,2-A][1,2] diazepin-1-carboxamide |
| 07/25/2001 | CN1305481A Piperazino derivatives as neurokinin antafonists |
| 07/25/2001 | CN1305480A Pyrolo [2,3-d] pyrimidine compounds |
| 07/25/2001 | CN1305479A Pyrrolo [2,3-d] pyrmidine compounds |
| 07/25/2001 | CN1305473A N,N-disubstituded amide for inhibit binding of integrins to their receptors protein |
| 07/25/2001 | CN1305467A Phthalazine derivatives phosphodiesterase 4 inhibitors |
| 07/25/2001 | CN1305465A Aryl alkanoylpyridazines |
| 07/25/2001 | CN1305464A Heterocyclic compounds and methods to treat cardiac failure and other disorders |
| 07/25/2001 | CN1305462A Novel 1,5 and 3-O-substituted 1H-indazoles with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effect, and method for the production and use thereof as medica |
| 07/25/2001 | CN1305458A Diarylselenide compounds and their use in human or veterinary medicine and in cosmetics |
| 07/25/2001 | CN1305385A Method and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 07/25/2001 | CN1305371A Multiparticulate pharmaceutical form with programmed and timed release and preparation method |
| 07/25/2001 | CN1304936A Quinoline-4-radical derivative II |
| 07/25/2001 | CN1304760A Plaster for treating ostalgia and its preparing process |
| 07/25/2001 | CN1304752A Clematis capsule and its preparing process |
| 07/25/2001 | CN1304747A Compound capsule for treating hyperosteogeny and rheumatism and its preparing process |
| 07/25/2001 | CN1304743A Medicine for treating injury |
| 07/25/2001 | CN1304742A Ointment for treating bone fracture and injury |
| 07/25/2001 | CN1304741A Lumbago plaster |
| 07/25/2001 | CN1304738A Quick-acting plaster for treating rheumatic arthritis |
| 07/25/2001 | CN1068879C Dihydrobenzofuranes |
| 07/24/2001 | US6265588 Use as pharmaceuticals; as an antigen for production of antibodies and in diagnosis and purification |
| 07/24/2001 | US6265578 Matrix metalloprotease inhibitors |
| 07/24/2001 | US6265572 Inhibit binding of integrin expressing cells to cell adhesion molecules of endothelium |
| 07/24/2001 | US6265564 Expressed ligand-vascular intercellular signalling molecule |
| 07/24/2001 | US6265562 Nucleotide sequences coding transcription factor; for the treatment and prevention of infection, tumors, leukemias, autoimmune disease, allergies, arthritis, inflammation, organ rejection, graft versus host disease and coagulation defects |
| 07/24/2001 | US6265560 Nucleotide sequences coding enzymatic polypeptide associated with signal transducton; for diagnosis, prevention, and treatment of inflammation, arthritis and physiological defects |
| 07/24/2001 | US6265550 Antibody; for use in the diagnosis, prevention, and treatment of cancer, inflammation, and insulin response defects |
| 07/24/2001 | US6265446 Antiinflammatory agents; autoimmune diseases |
| 07/24/2001 | US6265444 Ophthalmic composition |
| 07/24/2001 | US6265436 Substituted 5-biphenyl-3,4-dihydroxy-2(5H)-furanones and method of use therefor |
| 07/24/2001 | US6265434 Antiinflammatory agents |
| 07/24/2001 | US6265433 LTA4 hydrolase inhibitors |
| 07/24/2001 | US6265428 Vasodilation |
| 07/24/2001 | US6265423 Skin disorders; anticancer agents |
| 07/24/2001 | US6265410 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 07/24/2001 | US6265403 Angiogenesis inhibitors |
| 07/24/2001 | US6265375 Conformationally constrained backbone cyclized peptide analogs |
| 07/24/2001 | US6265184 Polynucleotides encoding chemokine receptor 88C |
| 07/24/2001 | US6264947 Genetic engineering; therapy for cancer, autoimmune diseases, reproduction, antiinflammatory agents |
| 07/24/2001 | US6264917 Targeted ultrasound contrast agents |